International Clinical Trial Center

The aim of the International Clinical Trial Center is to conduct successful international clinical research projects that lead to a better understanding of the biological basis of psychiatric disorders and improvements in patient care. This group is led by Dr. Inge Winter, senior trial manager with special expertise in the field of schizophrenia and related disorders who coordinated several large studies that provided fundamental evidence regarding optimal treatment of psychotic disorders. Inge is involved in several academic groups, including Oxford University, King’s College London and New York’s Sinai Medical Center. She manages a group of researchers who implement and coordinate large-scale trials across Europe and Israel, through funding by the European Commission, the Stanley Medical Research Institute and unrestricted grants. These trials mostly focus on the treatment of psychosis, although studies on major depressive disorder, Alzheimer's and autism have also been conducted. For most projects, the team takes on all clinical trial management responsibilities: from writing the protocol and Standard Operation Procedures, designing randomisation modules and the eCRF, centralised and on-site monitoring, safety reporting up until writing publications in international peer-reviewed journals.